$1.82
1.09%
Nasdaq, Nov 17, 04:00 pm EST. Closed.

Pacific Biosciences of California, Inc. Stock price

$1.82
-0.02 1.09% 1M
+0.67 58.26% 6M
-0.05 2.67% YTD
+0.25 15.92% 1Y
-6.58 78.33% 3Y
-25.23 93.27% 5Y
-5.83 76.21% 10Y
-14.62 88.93% 20Y
Nasdaq, Closing price Tue, Nov 17 2026
-0.02 1.09%

Is Pacific Biosciences of California, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,087 stocks worldwide.

Key metrics

Basic
Market capitalization
$575.8m
Enterprise Value
$983.3m
Net debt
$407.5m
Cash
$236.9m
Shares outstanding
310.8m
Valuation
P/E
negative
P/S | estimate
3.6 | 3.6
EV/Sales | estimate
6.2 | 6.1
EV/FCF | ex SBC
negative | negative
P/B
negative
Financial Health
Equity Ratio
0.7%
Return on Equity
-10,214.5%
ROCE
-22.8%
ROIC
-32.7%
Debt/Equity
-19.4
Share-Based Compensation & Dilution
SBC | % of Revenue
$34.3m | 21.5%
SBC as % of FCF
-
SBC Growth 1Y
-38.1%
Share Count Growth 1Y
3.5%
Shareholder Yield
-3.5%
Financials
Revenue | estimate
$159.3m | $160.8m
EBITDA
$-152.1m
EBIT
$-155.5m
Net Income
$-131.4m
Free Cash Flow | ex SBC
$-130.5m | $-164.8m
Growth
Revenue | estimate
2.0% | 0.5%
EBITDA
22.6%
EBIT
25.4%
Net Income
75.0%
Free Cash Flow
17.1%
Margin
Gross
39.2%
EBITDA
-95.5%
EBIT
-97.6%
Net
-82.5%
Free Cash Flow | ex SBC
-81.9% | -103.5%
More
EPS
$-0.4
FCF per Share
$-0.4
Short interest
19.8%
Employees
485
Rev per Employee
$330.0k

Pacific Biosciences of California, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Pacific Biosciences of California, Inc. forecast:

9x Buy
64%
4x Hold
29%
1x Sell
7%

Analyst Opinions

14 Analysts have issued a Pacific Biosciences of California, Inc. forecast:

Buy
64%
Hold
29%
Sell
7%

Pacific Biosciences of California, Inc. Events

Past Events
NOV
4
Q3 2026 Earnings Call
13 days ago
SEP
15
Morgan Stanley 24th Annual Global Healthcare Conference
2 months ago
AUG
5
Q2 2026 Earnings Call
3 months ago
MAY
7
Q1 2026 Earnings Call
6 months ago
FEB
12
Q4 2025 Earnings Call
9 months ago
JAN
12
44th Annual J.P. Morgan Healthcare Conference
10 months ago
NOV
5
Q3 2025 Earnings Call
about one year ago

Financial data from Pacific Biosciences of California, Inc.

Jun '26
+/-
%
159 159
2% 2%
100%
- Direct Costs 97 97
18% 18%
61%
62 62
67% 67%
39%
- Selling and Administrative Expenses 127 127
16% 16%
80%
- Research and Development Expense 88 88
14% 14%
55%
-152 -152
23% 23%
-96%
- Depreciation and Amortization 3.33 3.33
72% 72%
2%
EBIT (Operating Income) EBIT -155 -155
25% 25%
-98%
Net Profit -131 -131
75% 75%
-82%

In millions USD.

Don't miss a Thing! We will send you all news about Pacific Biosciences of California, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pacific Biosciences of California, Inc. Stock News

Neutral
GlobeNewsWire
●
about one hour ago
MENLO PARK, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Piper Sandler 38th Annual Healthcare Conference on Wednesday, December 2, 2026, at 9:30 AM ET in New York, New York.
Neutral
GlobeNewsWire
●
13 days ago
MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended September 30, 2026.
More Pacific Biosciences of California, Inc. News

Company Profile

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Head office United States
CEO Mr. Henry
Employees 485
Founded 2000
Website www.pacb.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today